Overview

Supply Chains & Logistics in the Pharmaceutical Industry

The healthcare and pharmaceutical sector is transforming rapidly with rising demand for biologics, patient-specific treatments, and flexible global distribution. Temperature-sensitive products like vaccines and GLP-1 drugs now represent nearly 45% of logistics costs, making robust cold chain management critical. Hatmill designs and optimises temperature-controlled networks to ensure compliance and efficiency.

Counterfeit drugs, estimated at 10-15% of global medicines, demand stricter compliance under frameworks like DSCSA and the EU Falsified Medicines Directive. Hatmill implements advanced serialisation, blockchain, IoT, RFID, and traceability solutions to safeguard product integrity and protect brand reputation.

Geopolitical disruptions, tariff shifts, and raw material shortages expose supply chain vulnerabilities. Hatmill builds resilience through strategic planning, risk modelling, supplier diversification, and predictive analytics. From robotic cold storage to AI-driven automation and autonomous delivery, we guide businesses in leveraging technology to improve efficiency and reduce temperature excursions.

Partnering with Hatmill ensures your supply chain is compliant, secure, resilient, and automated to meet patient needs in an increasingly complex global market.